Morecell Biomedical

Morecell Biomedical is a Taiwan-based biotechnology company specializing in regenerative medicine and advanced immune cell therapies. The company operates a high-standard Cell Processing Center (CPC) that complies with Good Tissue Practice (GTP) standards to provide cell processing and cryopreservation services. Their therapeutic pipeline focuses on Cytokine-Induced Killer (CIK) cells and Natural Killer (NK) cells for treating various solid tumors, as well as Adipose-Derived Stem Cells (ADSCs) for orthopedic and aesthetic applications. Morecell actively collaborates with major medical centers in Taiwan to provide clinical-grade cell therapy products under the country's specialized regulatory framework for regenerative medicine. The company aims to bridge the gap between laboratory research and clinical application to provide personalized treatment options for cancer and degenerative diseases.